Despite decades of research, billions of dollars spent worldwide, the development of many drugs, many failed clinical trials, and the extensive publication of research and other articles on the subject, it is clear that our approach to solving Parkinson's disease is not really working. Indeed, presently, no drug can cure or stop this disease from progressing! What is happening? Like in the case of Alzheimer's and other neurodegenerative diseases, Dr. Fymat believes we got the cause all wrong and, instead, of remaining focused on the primary end-point of a cure, the emphasis had shifted to…mehr
Despite decades of research, billions of dollars spent worldwide, the development of many drugs, many failed clinical trials, and the extensive publication of research and other articles on the subject, it is clear that our approach to solving Parkinson's disease is not really working. Indeed, presently, no drug can cure or stop this disease from progressing! What is happening? Like in the case of Alzheimer's and other neurodegenerative diseases, Dr. Fymat believes we got the cause all wrong and, instead, of remaining focused on the primary end-point of a cure, the emphasis had shifted to surrogate often uncorrelated, end-points. In this book, he elucidates the disease and attempts to reorient our approach along a path he is convinced will be more successful in leading us to a cure. He breaks down barriers to make research accessible and focuses on the important aspects of the underlying research. He distills this information and conveys to Parkinson's patients and their caregivers the results of research, including his own, on this devastating disease. He also reports on his breakthrough as to the underlying root cause of the disease, provides the outlines of his new approach, and even suggests the methodology to be followed.
DR. ALAIN L. FYMAT is a medical-physical scientist and an educator. He is the current President/ CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He was also Scientific Advisor to the U.S. National Academy of Sciences, National Research Council, for its postdoctoral programs tenable at the California Institute of Technology and Member of the Advisory Group for Research & Development, North Atlantic Treaty Organization (NATO). He is Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a member of the New York Academy of Sciences and the European Union Academy of Sciences, a Board member of several institutions, and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
